News articles about Hill-Rom (NYSE:HRC) have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Hill-Rom earned a news impact score of 0.18 on Accern’s scale. Accern also gave headlines about the medical technology company an impact score of 46.1416204947619 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
These are some of the headlines that may have effected Accern Sentiment’s rankings:
HRC has been the topic of a number of recent analyst reports. KeyCorp reissued a “buy” rating and set a $94.00 price target on shares of Hill-Rom in a research note on Thursday, December 21st. Raymond James Financial raised Hill-Rom from a “market perform” rating to an “outperform” rating and set a $94.00 price target on the stock in a research note on Wednesday, January 3rd. Zacks Investment Research lowered Hill-Rom from a “buy” rating to a “hold” rating in a research report on Tuesday, March 6th. Morgan Stanley lowered Hill-Rom from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, January 2nd. They noted that the move was a valuation call. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $105.00 target price (up from $90.00) on shares of Hill-Rom in a research report on Tuesday, January 16th. One analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the stock. Hill-Rom currently has a consensus rating of “Hold” and a consensus target price of $93.89.
Shares of HRC opened at $86.00 on Friday. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.29 and a current ratio of 1.75. The firm has a market capitalization of $5,698.22, a P/E ratio of 22.28, a PEG ratio of 1.38 and a beta of 0.97. Hill-Rom has a twelve month low of $69.47 and a twelve month high of $91.11.
Hill-Rom (NYSE:HRC) last issued its earnings results on Friday, January 26th. The medical technology company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.13. The business had revenue of $669.70 million for the quarter, compared to analyst estimates of $670.00 million. Hill-Rom had a return on equity of 20.24% and a net margin of 7.14%. The business’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period last year, the company posted $0.75 EPS. equities research analysts expect that Hill-Rom will post 4.62 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, March 30th. Investors of record on Friday, March 23rd were issued a $0.20 dividend. This is an increase from Hill-Rom’s previous quarterly dividend of $0.18. This represents a $0.80 annualized dividend and a yield of 0.93%. The ex-dividend date of this dividend was Thursday, March 22nd. Hill-Rom’s dividend payout ratio is currently 20.73%.
ILLEGAL ACTIVITY WARNING: “Hill-Rom (HRC) Earning Somewhat Positive News Coverage, Accern Reports” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/04/14/hill-rom-hrc-earning-somewhat-positive-news-coverage-accern-reports.html.
Hill-Rom Company Profile
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.